secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2026-09-01T11:30:38+00:00
Accession:  0001493152-26-040926
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus enters $100M ATM offering agreement with H.C. Wainwright
-----------------------------------------------------------------

- Amended and restated ATM agreement dated Aug 28, 2026, replacing June 2022 agreement with H.C. Wainwright.
- Company may sell up to $100M of common stock through Wainwright as sales agent or principal.
- Placement fee of 3.0% of gross sales price for agent sales; no obligation to sell any shares.
- Prospectus supplement filed Aug 31, 2026 under existing Form S-3 shelf registration (File No. 333-289573).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/0001493152-26-040926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-040926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer